State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of approximately 66 million shares of Medtronic PLC common stock, representing 5.2% of the class, based on a triggering event dated September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: State Street Corporation reported 66,055,969 shares of Medtronic PLC common stock beneficially owned as of September 30, 2026.
  • Percent of class: The reported stake equals 5.2% of Medtronic's outstanding common stock.
  • Shared voting power: State Street disclosed shared power to vote or direct the vote of 41,915,337 shares, with sole voting power of 0.
  • Shared dispositive power: The filing reports shared power to dispose or direct the disposition of 65,987,354 shares, with sole dispositive power of 0.
  • Reporting entity type: State Street Corporation identified itself as a parent holding company (type "HC"), organized in Massachusetts, with its principal office at One Congress Street, Suite 1, Boston, MA 02114.
  • Subsidiaries involved: The filing identifies ten investment adviser subsidiaries, including SSGA Funds Management, Inc. and multiple State Street Global Advisors entities across Japan, Asia, Europe, Singapore, Australia, and Saudi Arabia.

State Street's Medtronic Holdings Disclosed Through Global Adviser Network

State Street Corporation, the Boston-based parent holding company, submitted the Schedule 13G disclosing its aggregate position in Medtronic PLC, an Ireland-incorporated medical device company whose principal executive offices are listed in the filing at 20 Lower Hatch St, Dublin, Ireland, D02 XH02. The shares carry CUSIP number G5960L103 and are classified as common stock. State Street filed as a parent holding company under Item 3(g) of the schedule, meaning the reported holdings are accumulated across its network of investment adviser subsidiaries rather than held directly by the parent itself.

According to the filing, all voting and dispositive power is held on a shared basis, with no sole power reported in either category. The ten subsidiaries named as the acquiring entities all carry the classification "IA" (investment adviser), and they span operations in the United States, Japan, Asia, Europe, Singapore, Australia, and Saudi Arabia. The filing was signed by Alok Maheshwary, Senior Vice President of State Street Corporation, on November 9, 2026. The certification language in the filing states that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

Medtronic PLC is a global medical technology company; however, the Schedule 13G itself provides no information about the nature of the investment strategy, any specific funds involved, or whether the position has changed relative to prior filings. The filing does not indicate that Item 5 (ownership of 5 percent or less) or Item 8 (group membership) is applicable, and Item 6 (ownership on behalf of another person exceeding 5 percent) is listed as not applicable.

What Was Disclosed

State Street Corporation disclosed a 5.2% beneficial ownership position in Medtronic PLC common stock, totaling 66,055,969 shares, with all power held on a shared basis across ten investment adviser subsidiaries, as of September 30, 2026.